other material
confidence high
sentiment neutral
materiality 0.35
Estrella Immunopharma details $1M share repurchase: open market buys via 10b5-1 plan over 12 months
Estrella Immunopharma, Inc.
- Board authorized up to $1,000,000 in common stock repurchases (first announced Jan 30, 2024).
- Repurchases expected via open market trades at prevailing prices under a Rule 10b5-1 plan.
- Company will use existing cash reserves; plan may be modified or terminated based on market conditions.
- Expected to occur within the next 12 months.